Publisher's Synopsis
This comprehensive analysis gives an ethical perspective of the entire drug development process, comparing American and European approaches. It describes new approaches to the testing and pricing of drugs, while giving accounts of the development of thrombolytic therapy for heart attacks, and of the current rules for the approval of drugs adopted by the Federal Drug Authority in the USA.